• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

ViS

edit

ViS provides a game-changing analytics platform for the planning of clinical trials. Pharmaceutical trials are required for the evaluation of new medicines, and ViS’ collaborative analytics radically improves cost-efficiency in the selection of research centers for trial participation.

ViS provides the only interactive map of global clinical research infrastructure, which achieves two objectives: I) allows trial planners to quickly find centers and make sense of vast amounts of comparative multi-dimensional analytics, going easily from the country level down to that of the center; and II) enables the more than 400,000 globally distributed research centers to securely and efficiently showcase their technical disease-specific capabilities to trial planners, while also connecting with collaborating centers that can lead to future projects.

Recent Milestones

edit

• 
  ViS received $1.5M in Angel funding. (8/27/12)
  Posted 8/27/12 at 8:00am
• 
  ViS added Dan Martines as CIO. (6/1/12)
  Posted 8/27/12 at 8:00am
• 
  ViS added Gustavo Kesselring, MD as Head of Center Engagement and Executive Director LATAM.
  Posted 8/27/12 at 8:00am
• 
  ViS added Johanna Schenk, MD, FFPM as Head of Trial Planning and Executive Director Europe.
  Posted 8/27/12 at 8:00am
• 
  ViS added Jatin Shah, MD as Head of Research Intelligence & Executive Director Asia.
  Posted 8/27/12 at 8:00am
• 
  ViS added Fabio Thiers, MD, PhD as Founder and CEO.
  Posted 8/27/12 at 8:00am
• 
  ViS added James Rosenstein as Head of Global Communications.
  Posted 8/27/12 at 8:00am

Videos

Screenshots

edit

Sources

1. Self, Family & Friends [edit]